AAAAAA

   
Results: 1-10 |
Results: 10
Heterocycle-based MMP inhibitors with P2 ' substituents
Authors: Pikul, S Dunham, KM Almstead, NG De, B Natchus, MG Taiwo, YO Williams, LE Hynd, BA Hsieh, LC Janusz, MJ Gu, F Mieling, GE
Citation: S. Pikul et al., Heterocycle-based MMP inhibitors with P2 ' substituents, BIOORG MED, 11(8), 2001, pp. 1009-1013
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines
Authors: Natchus, MG Bookland, RG Laufersweiler, MJ Pikul, S Almstead, NG De, B Janusz, MJ Hsieh, LC Gu, F Pokross, ME Patel, VS Garver, SM Peng, SX Branch, TM King, SL Baker, TR Foltz, DJ Mieling, GE
Citation: Mg. Natchus et al., Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines, J MED CHEM, 44(7), 2001, pp. 1060-1071
Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis
Authors: Soper, DL Milbank, JBJ Mieling, GE Dirr, MJ Kende, AS Cooper, R Jee, WSS Yao, W Chen, JL Bodman, M Lundy, MW De, B Stella, ME Ebetino, FH Wang, YL deLong, MA Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis, J MED CHEM, 44(24), 2001, pp. 4157-4169
Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. (vol 44, pg 4157, 2001)
Authors: Soper, DL Milbank, JBJ Mieling, GE Dirr, MJ Kende, AS Chen, R Bodman, M Lundy, MW De, B Stella, ME Ebetino, FH Wang, YL deLong, MA Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. (vol 44, pg 4157, 2001), J MED CHEM, 44(24), 2001, pp. 4307-4307
Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases
Authors: Pikul, S Ohler, NE Ciszewski, G Laufersweiler, MC Almstead, NG De, B Natchus, MG Hsieh, LC Janusz, MJ Peng, SX Branch, TM King, SL Taiwo, YO Mieling, GE
Citation: S. Pikul et al., Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases, J MED CHEM, 44(16), 2001, pp. 2499-2502
Design and synthesis of 13,14-dihydro prostaglandin F-1 alpha analogues aspotent and selective ligands for the human FP receptor
Authors: Wang, YL Wos, JA Dirr, MJ Soper, DL deLong, MA Mieling, GE De, B Amburgey, JS Suchanek, EG Taylor, CJ
Citation: Yl. Wang et al., Design and synthesis of 13,14-dihydro prostaglandin F-1 alpha analogues aspotent and selective ligands for the human FP receptor, J MED CHEM, 43(5), 2000, pp. 945-952
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
Authors: Cheng, MY De, B Pikul, S Almstead, NG Natchus, MG Anastasio, MV McPhail, SJ Snider, CE Taiwo, YO Chen, LY Dunaway, CM Gu, F Dowty, ME Mieling, GE Janusz, MJ Wang-Weigand, S
Citation: My. Cheng et al., Design and synthesis of piperazine-based matrix metalloproteinase inhibitors, J MED CHEM, 43(3), 2000, pp. 369-380
Development of new hydroxamate matrix metalloproteinase inhibitors derivedfrom functionalized 4-aminoprolines
Authors: Natchus, MG Bookland, RG De, B Almstead, NG Pikul, S Janusz, MJ Heitmeyer, SA Hookfin, EB Hsieh, LC Dowty, ME Dietsch, CR Patel, VS Garver, SM Gu, F Pokross, ME Mieling, GE Baker, TR Foltz, DJ Peng, SX Bornes, DM Strojnowski, MJ Taiwo, YO
Citation: Mg. Natchus et al., Development of new hydroxamate matrix metalloproteinase inhibitors derivedfrom functionalized 4-aminoprolines, J MED CHEM, 43(26), 2000, pp. 4948-4963
Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors
Authors: Almstead, NG Bradley, RS Pikul, S De, B Natchus, MG Taiwo, YO Gu, F Williams, LE Hynd, BA Janusz, MJ Dunaway, CM Mieling, GE
Citation: Ng. Almstead et al., Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors, J MED CHEM, 42(22), 1999, pp. 4547-4562
Design and synthesis of phosphinamide-based hydroxamic acids as inhibitorsof matrix metalloproteinases
Authors: Pikul, S Dunham, KLM Almstead, NG De, B Natchus, MG Anastasio, MV McPhail, SJ Snider, CE Taiwo, YO Chen, LY Dunaway, CM Gu, F Mieling, GE
Citation: S. Pikul et al., Design and synthesis of phosphinamide-based hydroxamic acids as inhibitorsof matrix metalloproteinases, J MED CHEM, 42(1), 1999, pp. 87-94
Risultati: 1-10 |